并排上下 发表于 2025-3-23 12:54:29

Submitted on: 05 May 2007.
Revised on: 25 July 2007.
Accepted on: 04 September 2007.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

Synovial-Fluid 发表于 2025-3-23 16:25:23

http://reply.papertrans.cn/1/26/2595/2595-12.png

Counteract 发表于 2025-3-23 19:49:19

Submitted on: 27 February 2023.
Revised on: 14 May 2023.
Accepted on: 11 June 2023.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

alcohol-abuse 发表于 2025-3-23 23:11:32

Submitted on: 18 January 2015.
Revised on: 23 February 2015.
Accepted on: 05 March 2015.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

Kaleidoscope 发表于 2025-3-24 06:23:38

http://reply.papertrans.cn/1/26/2595/2595-15.png

Vital-Signs 发表于 2025-3-24 07:31:37

Submitted on: 26 May 2003.
Revised on: 03 July 2003.
Accepted on: 28 August 2003.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

含糊其辞 发表于 2025-3-24 12:34:49

http://reply.papertrans.cn/1/26/2595/2595-17.png

Enervate 发表于 2025-3-24 14:59:46

Submitted on: 04 October 2003.
Revised on: 26 November 2003.
Accepted on: 06 January 2004.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

Optometrist 发表于 2025-3-24 20:45:17

Submitted on: 29 April 2023.
Revised on: 08 July 2023.
Accepted on: 02 August 2023.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD

Veneer 发表于 2025-3-25 01:09:58

Submitted on: 12 April 2010.
Revised on: 05 June 2010.
Accepted on: 22 June 2010.

___________________Argumentation and Advocacy---ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
页: 1 [2] 3 4
查看完整版本: ESCI期刊Argumentation and Advocacy 2024/2025影响因子:0.511 (ARGUMENT ADVOCACY) (1051-1431). (COMMUNICATION)(通信)Emerging Sourc